
Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences like integrated electronic circuits. . . . → Read More: Gene Therapy Company Exploring DNA Circuit Technology
|
|||||
![]() Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences like integrated electronic circuits. . . . → Read More: Gene Therapy Company Exploring DNA Circuit Technology ![]() A study with lab mice shows an experimental vaccine with engineered bacteria produces antibodies and protects against microbes causing Lyme disease. . . . → Read More: Vaccine Stops Lyme Bacteria in Preclinical Test ![]() A clinical trial is underway testing for allergic reactions to Covid-19 vaccines using messenger RNA for invoking an immune response. . . . → Read More: NIH Trial Testing mRNA Vaccine Allergic Effects ![]() A biotechnology start-up is collaborating with Microsoft Corp. on computational tools to find and predict factors that cause cancers to spread. . . . → Read More: Microsoft, Biotech Partner on Metastatic Cancer ![]() An academic-industry team designed a computer chip with graphene circuits using the gene-editing technique Crispr to detect fine genetic differences in samples. . . . → Read More: Graphene Crispr Chip Detects Small Genetic Differences ![]() A clinical trial is set to begin that tests a direct form of gene editing with Crispr to correct inherited malfunctioning genes causing sickle cell disease. . . . → Read More: Trial to Test Direct Crispr Blood Stem Cell Edits ![]() Researchers at two Virginia universities developed an experimental vaccine that in tests with pigs protects against SARS-CoV-2 and other coronaviruses. . . . → Read More: Test Vaccine Protects Against Wide Coronavirus Range ![]() A venture capital company raised $50 million to invest in new businesses developing innovative products and services at the junction of biology and engineering. . . . → Read More: Venture Fund to Support Seed-Stage Biotechs ![]() A new company is beginning work on a safer form of cancer immunotherapy that avoids toxic off-target effects, and raising $55 million in venture funds. . . . → Read More: Precision Cancer Immunotherapy Biotech Underway ![]() A company creating biologics derived from synthetic DNA and genes discovered antibodies that control blood glucose levels in lab animals. . . . → Read More: Synthetic Antibodies Shown to Control Blood Glucose |
|||||
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |